Deka Biosciences
Manufacturing · Maryland, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
20271 Goldenrod Ln, Germantown, Maryland...Phone Number
(301) 256-4776Website
www.dekabiosciences.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Deka Biosciences
Deka BioSciences, Inc., located in Germantown, Maryland, is committed to developing and delivering life-changing medicines to patients diagnosed with cancer and inflammatory diseases.Explore more
Deka Biosciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Deka Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Deka Biosciences had a recent Job posting/layoffs
Check out if Deka Biosciences is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Deka Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Deka Biosciences has new funding data
Earning: See what the market has to say on Deka Biosciences recently announced quarterly report
Product Launch: Get notified when Deka Biosciences launches new products
Check if Deka Biosciences has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Deka Biosciences
Recommended Actions
Find VP level buyers at Deka Biosciences
Find more new buyers
Compare Similar Companies to Deka Biosciences
Compare insights from companies similar to Deka Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Deka Biosciences
<$5M
1-10
Private
$40M
2019
SF
Stanley FrankelSenior Clinical Advisor and Interim Chief Medical Officer
Company Profile Activity
Activity Insights
Deka Biosciences is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Deka Biosciences is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Deka Biosciences.
Deka Biosciences financials insights
Gather financial insights about Deka Biosciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Series A
$20M
2023
Series B
$20M
Deka Biosciences Tech Stack
A closer look at the technologies used by Deka Biosciences
See more technologies
Most Recent Scoops
New Hire
Executive Move
Board of Directors
Executive Move
Board of Directors
Funding
New Hire
Executive Move
Debra Kientop has been named Vice President, Clinical Operations. Previously, Kientop served as Senior Vice President, Oncology Strategy and Innovation for ErgoMed.
New Hire
Executive Move
Deka Biosciences News & Media
Deka Biosciences Closes USD $20 Million Series B2 Financing Led by MPM BioImpact
GERMANTOWN, Md., Sept. 28, 2023 /PRNewswire/ -- Maryland-based biotech company Deka Biosciences ("Deka") today announced that it has successfully closed a USD $20 Million Series B2 financing with a syndicate of life science investors led by MPM BioImpact, and joined by additional...Deka Biosciences Announces First-in-Human Dose in Phase 1 Clinical Trial of DK210 (EGFR)
GERMANTOWN, Md., April 5, 2023 /PRNewswire/ -- Deka Biosciences ("Deka"), a clinical-stage biotechnology company focused on developing novel cytokine therapies to treat cancer and inflammatory diseases, announced today that the first subject has been dosed in a Phase 1 clinical trial of...Deka Biosciences Receives FDA Clearance of DK210 (EGFR) Investigational New Drug Application
GERMANTOWN, Md., Jan. 30, 2023 /PRNewswire/ -- Deka Biosciences ("Deka"), a biotech company focused on developing novel cytokine therapies to treat cancer and inflammatory diseases, today announced that the U.S. Food and Drug Administration (FDA) has completed its review of the...Deka Biosciences, Inc Announces Submission of Investigational New Drug (IND) Application for Lead Oncology Asset, DK210 (EGFR)
Important Regulatory Milestone Provides Runway to Move DK210 (EGFR) into the Clinical Phase GERMANTOWN, Md., Dec. 27, 2022 /PRNewswire/ -- Today, Deka Biosciences, Inc. (Deka), a biotech company focused on developing novel cytokine therapies to treat cancer and inflammatory diseases,...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Deka Biosciences
Sign Up For FreeTo access detailed company insights
Deka BioSciences, Inc., located in Germantown, Maryland, is committed to developing and delivering life-changing medicines to patients diagnosed with cancer and inflammatory diseases.... Read More
